CELGENE CORP /DE/ Insider Trading $XLRN ACCELERON PHARMA INC
Get free email notifications about insider trading for CELGENE CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and 10% Owner in CELGENE CORP /DE/ ($CELG) and 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and in ACCELERON PHARMA INC ($XLRN) and 10% Owner in ACCELERON PHARMA INC ($XLRN) and in SUTRO BIOPHARMA INC ($STRO) and 10% Owner in Abraxis BioScience, Inc. ($ABII) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in CRISPR Therapeutics AG ($CRSP).
CELGENE CORP /DE/ in ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $166,435,229
Latest Transaction: Jul 13 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CELGENE CORP /DE/ in ACCELERON PHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 5.88 | 38,979 | 229,197 | 0 | |
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 102.28 | 2,241 | 229,209 | 7,008,510 | 7 M to 7 M (-0.03 %) |
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | X | 5.88 | 38,979 | 229,197 | 7,010,751 | 7 M to 7 M (+0.56 %) |
Jul 06 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 92.50 | 108,108 | 9,999,990 | 6,971,772 | 6.9 M to 7 M (+1.58 %) |
Jan 22 2019 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | Buy | P | 43.00 | 706,206 | 30,366,858 | 6,824,685 | 6.1 M to 6.8 M (+11.54 %) | |
Sep 25 2017 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 37.00 | 745,592 | 27,586,904 | 6,118,479 | 5.4 M to 6.1 M (+13.88 %) |
Jan 11 2016 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 40.00 | 800,000 | 32,000,000 | 5,372,887 | 4.6 M to 5.4 M (+17.49 %) |
May 06 2014 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 42.86 | 1,100,000 | 47,146,000 | 4,572,887 | 3.5 M to 4.6 M (+31.67 %) |
Jan 29 2014 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 50.00 | 300,000 | 15,000,000 | 3,472,887 | 3.2 M to 3.5 M (+9.46 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 1,990,446 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | J | 0.00 | 36,496 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 15.00 | 666,667 | 10,000,005 | 3,172,887 | 2.5 M to 3.2 M (+26.60 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 1,990,446 | 0 | 2,506,220 | 515.8 K to 2.5 M (+385.91 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 57,899 | 0 | 515,774 | 457.9 K to 515.8 K (+12.65 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 457,875 | 0 to 457.9 K |
Page: 1